These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 26219838)

  • 21. Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma.
    Chambrier C; Bastard JP; Rieusset J; Chevillotte E; Bonnefont-Rousselot D; Therond P; Hainque B; Riou JP; Laville M; Vidal H
    Obes Res; 2002 Jun; 10(6):518-25. PubMed ID: 12055328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.
    Sharma AM; Staels B
    J Clin Endocrinol Metab; 2007 Feb; 92(2):386-95. PubMed ID: 17148564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review.
    Lombardo YB; Chicco AG
    J Nutr Biochem; 2006 Jan; 17(1):1-13. PubMed ID: 16214332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype.
    Titos E; Rius B; González-Périz A; López-Vicario C; Morán-Salvador E; Martínez-Clemente M; Arroyo V; Clària J
    J Immunol; 2011 Nov; 187(10):5408-18. PubMed ID: 22013115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipid signaling in adipose tissue: Connecting inflammation & metabolism.
    Masoodi M; Kuda O; Rossmeisl M; Flachs P; Kopecky J
    Biochim Biophys Acta; 2015 Apr; 1851(4):503-18. PubMed ID: 25311170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation.
    Neuhofer A; Zeyda M; Mascher D; Itariu BK; Murano I; Leitner L; Hochbrugger EE; Fraisl P; Cinti S; Serhan CN; Stulnig TM
    Diabetes; 2013 Jun; 62(6):1945-56. PubMed ID: 23349501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stearidonic-Enriched Soybean Oil Modulates Obesity, Glucose Metabolism, and Fatty Acid Profiles Independently of Akkermansia muciniphila.
    Segura Munoz RR; Quach T; Gomes-Neto JC; Xian Y; Pena PA; Weier S; Pellizzon MA; Kittana H; Cody LA; Geis AL; Heck K; Schmaltz RJ; Bindels LB; Cahoon EB; Benson AK; Clemente TE; Ramer-Tait AE
    Mol Nutr Food Res; 2020 Sep; 64(17):e2000162. PubMed ID: 32656952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous ω-3 polyunsaturated fatty acid production confers resistance to obesity, dyslipidemia, and diabetes in mice.
    Li J; Li FR; Wei D; Jia W; Kang JX; Stefanovic-Racic M; Dai Y; Zhao AZ
    Mol Endocrinol; 2014 Aug; 28(8):1316-28. PubMed ID: 24978197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
    Molfino A; Amabile MI; Monti M; Muscaritoli M
    Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized controlled trial.
    Itariu BK; Zeyda M; Hochbrugger EE; Neuhofer A; Prager G; Schindler K; Bohdjalian A; Mascher D; Vangala S; Schranz M; Krebs M; Bischof MG; Stulnig TM
    Am J Clin Nutr; 2012 Nov; 96(5):1137-49. PubMed ID: 23034965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutrigenomics of ω-3 fatty acids: Regulators of the master transcription factors.
    Rodríguez-Cruz M; Serna DS
    Nutrition; 2017 Sep; 41():90-96. PubMed ID: 28760435
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Docosahexaenoic Acid-Derived Fatty Acid Esters of Hydroxy Fatty Acids (FAHFAs) With Anti-inflammatory Properties.
    Kuda O; Brezinova M; Rombaldova M; Slavikova B; Posta M; Beier P; Janovska P; Veleba J; Kopecky J; Kudova E; Pelikanova T; Kopecky J
    Diabetes; 2016 Sep; 65(9):2580-90. PubMed ID: 27313314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fish Oil Improves Pathway-Oriented Profiling of Lipid Mediators for Maintaining Metabolic Homeostasis in Adipose Tissue of Prediabetic Rats.
    Dasilva G; Lois S; Méndez L; Miralles-Pérez B; Romeu M; Ramos-Romero S; Torres JL; Medina I
    Front Immunol; 2021; 12():608875. PubMed ID: 33968013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial.
    Fisk HL; Childs CE; Miles EA; Ayres R; Noakes PS; Paras-Chavez C; Kuda O; Kopecký J; Antoun E; Lillycrop KA; Calder PC
    EBioMedicine; 2022 Mar; 77():103909. PubMed ID: 35247847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of eicosapentaenoic acid (EPA) treatment on insulin sensitivity in an animal model of diabetes: improvement of the inflammatory status.
    Figueras M; Olivan M; Busquets S; López-Soriano FJ; Argilés JM
    Obesity (Silver Spring); 2011 Feb; 19(2):362-9. PubMed ID: 20885391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: a critical reassessment.
    Billman GE
    Pharmacol Ther; 2013 Oct; 140(1):53-80. PubMed ID: 23735203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral ω-3 PUFA supplementation modulates inflammation in adipose tissue depots in morbidly obese women: A randomized trial.
    Bakker N; Hickey M; Shams R; Rivera CF; Vlahos J; Cense HA; Demirkiran A; Ramkhelawon B; Houdijk AP
    Nutrition; 2023 Jul; 111():112055. PubMed ID: 37182400
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue.
    Lappas M
    Metabolism; 2014 Feb; 63(2):250-62. PubMed ID: 24262292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-3 Polyunsaturated Fatty Acids and Gut Microbiota.
    Jayapala HPS; Lim SY
    Comb Chem High Throughput Screen; 2023; 26(5):892-905. PubMed ID: 35786331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against the Metabolic Syndrome by Guar Gum-Derived Short-Chain Fatty Acids Depends on Peroxisome Proliferator-Activated Receptor γ and Glucagon-Like Peptide-1.
    den Besten G; Gerding A; van Dijk TH; Ciapaite J; Bleeker A; van Eunen K; Havinga R; Groen AK; Reijngoud DJ; Bakker BM
    PLoS One; 2015; 10(8):e0136364. PubMed ID: 26292284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.